Colchicine
FDA Approved
Description
Colchicine is an anti-inflammatory agent that inhibits microtubule polymerization by binding to tubulin. It is used to treat inflammatory conditions including Behçet's disease and related autoinflammatory syndromes. The drug has been used for decades and has established efficacy in reducing inflammatory episodes.
Indications & Therapeutic Use
Behçet's disease, familial Mediterranean fever, gout, pericarditis
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Colchicine
| Generic Name | Colchicine |
| Brands | 1 brand available |
| Active Ingredient | Colchicine |
| Drug Class | Behçet's disease |
| Manufacturer | Takeda Pharmaceuticals |
| Dosage Forms | Oral tablet, 0.6mg |
| Medical Code | M04AC01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00848406 |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes